Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions & Guidelines
How We Work
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
Contact Us
Takeda Global Headquarters in Tokyo, Japan
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
Find out Takeda's stories related on Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
An Empowered Women-led Workforce
Heritage
Keys to Aging Gracefully
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
SDGs
Sustainable Value Report
Takeda is committed to contributing to the long-term health of people through disease prevention.
LEARN MORE
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
In the News
Featured Topics
Corporate Materials
Social Media
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
April 2018
April 25, 2018
4/25/2018
Takeda Announces Voluntary and Conditional Public Takeover Bid for TiGenix
April 25, 2018
4/25/2018
Takeda notes statement by Shire plc regarding revised proposal and extension of PUSU deadline to May 8, 2018
April 24, 2018
4/24/2018
Takeda Statement Regarding Shire plc
April 20, 2018
4/20/2018
Takeda Statement Regarding Improved Proposal for Shire plc
April 19, 2018
4/19/2018
Takeda Statement Regarding Shire plc
April 13, 2018
4/13/2018
Shonan Health Innovation Park Grand Opening
April 6, 2018
4/6/2018
Takeda Statement Regarding Press Reports
April 5, 2018
4/5/2018
Takeda Pharmaceutical and DNDi Collaborate to Progress a Potential New Drug for Visceral Leishmaniasis through the R&D Pipeline
April 5, 2018
4/5/2018
Takeda Announces Divestment of Multilab to Novamed
1
2
3
4
5
TOP
